5-AMINO-3-(3,6,7-TRIDEOXY-.ALPHA.-L-LYXO-HEPTOFURANOSYL)THIAZOLO(4,5-D)PYRIMIDINE-2,7(3H,6H)-DIONE
UNII BVX97E1NQB
Substance Identification & Data
This profile provides standardized clinical and technical data for 5-amino-3-(3,6,7-trideoxy-.alpha.-l-lyxo-heptofuranosyl)thiazolo(4,5-d)pyrimidine-2,7(3h,6h)-dione, uniquely identified by the FDA Unique Ingredient Identifier (UNII) BVX97E1NQB.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 1948244-34-5 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C12H16N4O5S SFUOKIWAHYUWBI-LKCKTBJASA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for 5-amino-3-(3,6,7-trideoxy-.alpha.-l-lyxo-heptofuranosyl)thiazolo(4,5-d)pyrimidine-2,7(3h,6h)-dione. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.